| Andrew D Petersen, DO | |
|
524 W 300 N Ste 203, Provo, UT 84601-2669 | |
| (801) 607-5268 | |
| (801) 607-5271 |
| Full Name | Andrew D Petersen |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 524 W 300 N Ste 203, Provo, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124011572 | NPI | - | NPPES |
| 184033201 | Medicaid | TX | |
| 207Q00000X | Other | KS | TAXONOMY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | M4441 (Texas) | Secondary |
| 207Q00000X | Family Medicine | 8382699-1204 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Andrew D Petersen, DO 524 W 300 N Ste 203, Provo, UT 84601-2669 Ph: (801) 607-5268 | Andrew D Petersen, DO 524 W 300 N Ste 203, Provo, UT 84601-2669 Ph: (801) 607-5268 |
News Archive
New research has provided the first evidence that 'gender bending' chemicals which find their way from human products into rivers and oceans can have a significant impact on the ability of fish to breed in UK Rivers.
Merck, known as MSD outside the United States and Canada, today announced the first presentation of preliminary data from a Phase 1 clinical trial evaluating MK-1454, an investigational STING (stimulator of interferon genes) agonist, as monotherapy and in combination with KEYTRUDA (pembrolizumab), Merck's anti-PD-1 therapy, in patients with advanced solid tumors or lymphomas.
Researchers found a small molecule that inhibits different virus proteins and significantly reduces infection in cells. Combined with the antiviral remdesivir, its potency increases significantly, suggesting it may be a potential antiviral candidate for the treatment of COVID-19.
Liquidia Technologies today announced a collaboration with the PATH Malaria Vaccine Initiative (MVI) to explore the use of the company's PRINT® particle technology to design next generation malaria vaccines. PRINT technology offers unprecedented control of particle size, shape and chemistry in a highly consistent and scalable manufacturing process, and will be used to deliver a protein in combination with immune stimulating molecules.
› Verified 1 days ago
Dr. Robert Joel Bush, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 750 N Freedom Blvd Ste 300, Provo, UT 84601 Phone: 801-852-1443 | |
Janee Namealoha Sells, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 3200 N Canyon Rd Ste C, Provo, UT 84604 Phone: 385-375-8724 | |
Dr. Marlin L Christianson, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 475 West 940 North, Provo, UT 84604 Phone: 801-357-7930 Fax: 801-357-7014 | |
Tyson Schwab, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 395 W Bulldog Blvd Ste 205, Provo, UT 84604 Phone: 801-357-1770 | |
Mr. Gregory Lawrence Nielsen, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1750 N Wymount Terrace Dr, Provo, UT 84604 Phone: 801-422-2771 Fax: 801-422-0761 | |
Mr. Tyler Jason Fieldsted, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 475 W 940 N, Provo, UT 84604 Phone: 801-357-7926 Fax: 801-357-7927 | |
Dr. Matthew Craig Evans, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1157 N 300 W, #201, Provo, UT 84604 Phone: 801-581-2000 |